Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carlos Augusto de Andrade"'
Autor:
Rafael Corrêa Coelho, Tomás Reinert, Franz Campos, Fábio Affonso Peixoto, Carlos Augusto de Andrade, Thalita Castro, Daniel Herchenhorn
Publikováno v:
International Brazilian Journal of Urology, Vol 42, Iss 4, Pp 694-703
ABSTRACT Purpose: The aim of this study was to assess the impact of sunitinib treatment in a non-screened group of patients with metastatic renal cell cancer (mRCC) treated by the Brazilian Unified Health System (SUS) at a single reference institutio
Externí odkaz:
https://doaj.org/article/11c890f3b9024c64b523da4baaddb828
Autor:
Fábio Affonso Peixoto, Thalita Castro, Daniel Herchenhorn, Rafael Coelho, Carlos Augusto de Andrade, Tomás Reinert, Franz Campos
Publikováno v:
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
International braz j urol v.42 n.4 2016
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU
International Brazilian Journal of Urology, Vol 42, Iss 4, Pp 694-703
International braz j urol, Volume: 42, Issue: 4, Pages: 694-703, Published: AUG 2016
International braz j urol v.42 n.4 2016
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU
International Brazilian Journal of Urology, Vol 42, Iss 4, Pp 694-703
International braz j urol, Volume: 42, Issue: 4, Pages: 694-703, Published: AUG 2016
Purpose: The aim of this study was to assess the impact of sunitinib treatment in a non-screened group of patients with metastatic renal cell cancer (mRCC) treated by the Brazilian Unified Health System (SUS) at a single reference institution. Materi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a6488bf4f9c55e216bb7522141d1fb5
http://europepmc.org/articles/PMC5006764
http://europepmc.org/articles/PMC5006764
Autor:
Neeta Sinha, Steven R. Arikian, Amit Sadana, Andre M. Murad, Christopher M. Dezii, Carlos Delfino, John Doyle, Carlos Augusto de Andrade
Publikováno v:
Clinical Drug Investigation. 13:90-98
The treatment of colorectal cancer continues to pose major challenges for oncologists throughout the world. Uracil and tegafur (UFT), as an oral agent, represents a new patient-focused approach to managing a malignancy with few treatment alternatives
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f14214e1994243e38f1204333ed4b499
https://doi.org/10.2165/00044011-199713020-00005
https://doi.org/10.2165/00044011-199713020-00005